NO20004980L - Partikulære varer av aktive ingredienser for den pulmonale anvendelsen - Google Patents

Partikulære varer av aktive ingredienser for den pulmonale anvendelsen

Info

Publication number
NO20004980L
NO20004980L NO20004980A NO20004980A NO20004980L NO 20004980 L NO20004980 L NO 20004980L NO 20004980 A NO20004980 A NO 20004980A NO 20004980 A NO20004980 A NO 20004980A NO 20004980 L NO20004980 L NO 20004980L
Authority
NO
Norway
Prior art keywords
active ingredients
particulate
pulmonary use
particulate articles
pulmonary
Prior art date
Application number
NO20004980A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004980D0 (no
Inventor
Holger Bengs
Juergen Grande
Original Assignee
Axiva Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axiva Gmbh filed Critical Axiva Gmbh
Publication of NO20004980D0 publication Critical patent/NO20004980D0/no
Publication of NO20004980L publication Critical patent/NO20004980L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20004980A 1998-04-09 2000-10-03 Partikulære varer av aktive ingredienser for den pulmonale anvendelsen NO20004980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19816085 1998-04-09
PCT/EP1999/002385 WO1999052506A1 (fr) 1998-04-09 1999-04-08 Excipient de principe actif particulaire destine a une application pulmonaire

Publications (2)

Publication Number Publication Date
NO20004980D0 NO20004980D0 (no) 2000-10-03
NO20004980L true NO20004980L (no) 2000-12-08

Family

ID=7864224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004980A NO20004980L (no) 1998-04-09 2000-10-03 Partikulære varer av aktive ingredienser for den pulmonale anvendelsen

Country Status (12)

Country Link
EP (1) EP1069889B1 (fr)
JP (1) JP2002511399A (fr)
KR (1) KR20010034755A (fr)
CN (1) CN1423553A (fr)
AT (1) ATE270097T1 (fr)
AU (1) AU3421099A (fr)
CA (1) CA2340340A1 (fr)
DE (1) DE59909854D1 (fr)
HU (1) HUP0101912A2 (fr)
NO (1) NO20004980L (fr)
PL (1) PL343342A1 (fr)
WO (1) WO1999052506A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19847593A1 (de) * 1998-10-15 2000-04-20 Aventis Res & Tech Gmbh & Co Zusammensetzung für die parenterale Applikation von Wirkstoffen
PT1808438E (pt) 1999-06-29 2015-01-14 Mannkind Corp Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE385193T1 (de) 2002-03-20 2008-02-15 Mannkind Corp Inhalationsgerät
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
BRPI0514263B8 (pt) 2004-08-20 2021-05-25 Mannkind Corp método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
JP5599975B2 (ja) 2006-02-22 2014-10-01 マンカインド コーポレイション ジケトピペラジン及び活性薬剤を含有する微粒子の製剤特性の改善方法
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2904623T3 (es) 2008-06-20 2022-04-05 Mannkind Corp Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
RU2509555C2 (ru) 2009-06-12 2014-03-20 Маннкайнд Корпорейшн Микрочастицы дикетопиперазина с определенными удельными площадями поверхности
CA2765156C (fr) 2009-06-12 2018-04-10 Mannkind Corporation Microparticules de dicetopiperazine avec teneurs en isomere definies
CA2778698A1 (fr) 2009-11-03 2011-05-12 Mannkind Corporation Appareil et methode de simulation d'efforts d'inhalation
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
US8925726B2 (en) 2011-04-01 2015-01-06 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
MX354163B (es) 2012-07-12 2018-02-15 Mannkind Corp Sistemas y métodos de suministro de fármaco en polvo seco.
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
SG10201708090TA (en) 2013-03-15 2017-11-29 Mannkind Corp Microcrystalline diketopiperazine compositions and methods
KR102321339B1 (ko) 2013-07-18 2021-11-02 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
CA2920488C (fr) 2013-08-05 2022-04-26 Mannkind Corporation Appareil d'insufflation et procedes
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2018222581A1 (fr) * 2017-05-29 2018-12-06 Resinnate Therapeutics Llc Méthodes et formulations pour l'administration de bêta-glucane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
DE19737481A1 (de) * 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel

Also Published As

Publication number Publication date
WO1999052506A1 (fr) 1999-10-21
AU3421099A (en) 1999-11-01
PL343342A1 (en) 2001-08-13
HUP0101912A2 (hu) 2001-10-28
CN1423553A (zh) 2003-06-11
WO1999052506B1 (fr) 1999-11-25
DE59909854D1 (de) 2004-08-05
ATE270097T1 (de) 2004-07-15
NO20004980D0 (no) 2000-10-03
CA2340340A1 (fr) 1999-10-21
JP2002511399A (ja) 2002-04-16
KR20010034755A (ko) 2001-04-25
EP1069889A1 (fr) 2001-01-24
EP1069889B1 (fr) 2004-06-30

Similar Documents

Publication Publication Date Title
NO20004980L (no) Partikulære varer av aktive ingredienser for den pulmonale anvendelsen
CN100543427C (zh) 碳酸钙颗粒
RU2008112146A (ru) Композиции и способы получения слаборастворимых в воде лекарственных средств с увеличенной стабильностью
DK1441704T3 (da) Orodispersibel tablet med höj homogenitet og fremgangsmåde til fremstilling heraf
MY129282A (en) Aerosolizable particles resistant to hygroscopic growth
ATE73472T1 (de) Verfahren zur herstellung eines systems zur kontrollierten abgabe von calcium.
MY139606A (en) Sustained-release composition and process for producing the same
DK486189D0 (da) Psyllium-froeskaller og midler omfattende samme
Bowyer Osteophagia and antler breakage among Roosevelt elk.
KR100740370B1 (ko) 아스코르브산 및 펙틴을 포함하는 조성물
WO2005084703A1 (fr) Composition a liberation soutenue pour cavite buccale
JPH0651628B2 (ja) 栄養剤組成物
CN113081893A (zh) 口腔抑菌组合物、制备方法及其应用
KR101861658B1 (ko) 미네랄을 포함하는 겔 조성물
BRPI0212195B1 (pt) Composições contendo pectina e ácido ascórbico
RU97114578A (ru) Биологически активная добавка к пище "коррида" для отвыкания от курения
JPS62228272A (ja) 安定なペルオキシダ−ゼ製剤
JPH06247860A (ja) グアーガム酵素分解物を有効成分とする鉄吸収促進剤
JP3054998B2 (ja) 粉末乳酸及び又は粉末乳酸塩の製造法
JP2616822B2 (ja) カルシウム製剤
JP7429076B1 (ja) 乳酸菌含有粉体、除菌剤、口腔ケア剤
JP2602712B2 (ja) ヘム鉄含有組成物
CA2524802C (fr) Compositions edulcorantes
CN109620841A (zh) 一种阿拉伯半乳聚糖基纳米硒及其制备方法和应用
JP2000245374A (ja) 品質の改良された麺類、その製造法および品質改良剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application